Identification of “Multiple Components-Multiple Targets-Multiple Pathways” Associated with Naoxintong Capsule in the Treatment of Heart Diseases Using UPLC/Q-TOF-MS and Network Pharmacology

Naoxintong capsule (NXT) is a commercial medicinal product approved by the China Food and Drug Administration which is used in the treatment of stroke and coronary heart disease. However, the research on the composition and mechanism of NXT is still lacking. Our research aimed to identify the absorb...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xianghui, Lv, Bin, Li, Pan, Jiang, Xiaoqing, Zhou, Qian, Wang, Xiaoying, Gao, Xiumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830706/
https://www.ncbi.nlm.nih.gov/pubmed/27123036
http://dx.doi.org/10.1155/2016/9468087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830706/
https://www.ncbi.nlm.nih.gov/pubmed/27123036
http://dx.doi.org/10.1155/2016/9468087

Ejemplares similares